Bayer Animal Health announces the launch of Coraxis (moxidectin) topical solution for dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and controls hookworms, roundworms, and whipworms in dogs. The product is expected to be available for sale in early February. “Coraxis is a unique addition to the veterinarian’s anti-parasite toolbox,” said […]
Read More
BerGenBio ASA announces that the first patient has been dosed in a phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumour efficacy of ADCT-601, an AXL-targeting antibody drug conjugate (ADC), in patients with advanced solid tumours. ADCT-601 is composed of a humanised monoclonal antibody against human AXL (BGB601) discovered by BerGenBio, conjugated to […]
Read More